Hooper Holmes (HH) 10-Q 14 Nov 16 2016 Q3 Quarterly report Financial data

DEI Document

DEI Document - shares	9 Months Ended
	Sep. 30, 2016	Oct. 31, 2016
DEI [Abstract]
Entity Registrant Name	HOOPER HOLMES INC
Entity Central Index Key	741,815
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		10,103,525

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
ASSETS
Cash and cash equivalents	$ 825	$ 2,035
Accounts receivable, net of allowance for doubtful accounts of $118 and $112 at September 30, 2016 and December 31, 2015, respectively	7,403	5,565
Inventories	1,481	567
Other current assets	431	331
Total current assets	10,140	8,498
Property, plant and equipment	8,710	8,427
Less: Accumulated depreciation and amortization	6,771	5,656
Property, plant and equipment, net	1,939	2,771
Intangible assets, net	4,356	5,331
Goodwill	633	633
Other assets	394	450
Total assets	17,462	17,683
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Accounts payable	5,555	5,339
Accrued expenses	2,526	2,313
Short-term debt	6,924	5,330
Other current liabilities	2,591	2,873
Total current liabilities	17,596	15,855
Other long-term liabilities	444	1,611
Commitments and contingencies
Stockholders' (deficit) equity:
Common stock, par value $.04 per share; Authorized: 240,000,000 shares; Issued: 10,047,969 shares at September 30, 2016, and 5,201,733 shares at December 31, 2015; Outstanding: 10,047,969 shares at September 30, 2016, and 5,201,107 shares at December 31, 2015	402	3,121
Additional paid-in capital	165,988	156,195
Accumulated deficit	(166,968)	(159,028)
Stockholders' (deficit) equity	(578)	288
Less: Treasury stock, at cost; 0 and 626 shares at September 30, 2016, and December 31, 2015	0	(71)
Total stockholders' (deficit) equity	(578)	217
Total liabilities and stockholders' (deficit) equity	$ 17,462	$ 17,683

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 118	$ 112
Common stock, par value (in dollars per share)	$ 0.04	$ 0.04
Common stock, shares authorized (in shares)	240,000,000	240,000,000
Common stock, shares issued (in shares)	10,047,969	5,201,733
Common stock, shares outstanding (in shares)	10,047,969	5,201,107
Treasury stock (in shares)	0	626

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
Revenues	$ 9,750	$ 9,272	$ 24,634	$ 22,615
Cost of operations	7,282	7,143	18,941	18,060
Gross profit	2,468	2,129	5,693	4,555
Selling, general and administrative expenses	3,586	3,740	11,138	10,212
Transaction costs	50	57	379	737
Operating loss from continuing operations	(1,168)	(1,668)	(5,824)	(6,394)
Interest expense, net	878	388	2,678	1,097
Other income	0	0	(887)	0
Loss from continuing operations before taxes	(2,046)	(2,056)	(7,615)	(7,491)
Income tax expense	5	5	15	15
Loss from continuing operations	(2,051)	(2,061)	(7,630)	(7,506)
Discontinued operations:
Loss from discontinued operations	(1)	(57)	(310)	(82)
Net loss	$ (2,052)	$ (2,118)	$ (7,940)	$ (7,588)
Continuing operations
Basic (in dollars per share)	$ (0.22)	$ (0.40)	$ (0.89)	$ (1.49)
Diluted (in dollars per share)	(0.22)	(0.40)	(0.89)	(1.49)
Discontinued operations
Basic (in dollars per share)	0	(0.01)	(0.04)	(0.02)
Diluted (in dollars per share)	0	(0.01)	(0.04)	(0.02)
Net loss
Basic (in dollars per share)	(0.22)	(0.41)	(0.93)	(1.51)
Diluted (in dollars per share)	$ (0.22)	$ (0.41)	$ (0.93)	$ (1.51)
Weighted average number of shares - Basic (in shares)	9,149,418	5,185,986	8,604,846	5,026,095
Weighted average number of shares - Diluted (in shares)	9,149,418	5,185,986	8,604,846	5,026,095

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) - 9 months ended Sep. 30, 2016 - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock
Balance (in shares) at Dec. 31, 2015		5,201,733			626
Balance at Dec. 31, 2015	$ 217	$ 3,121	$ 156,195	$ (159,028)	$ (71)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,940)			(7,940)
Issuance of common stock and warrants, net of issuance costs (in shares)		4,601,789
Issuance of common stock and warrants, net of issuance costs	6,183	$ 2,014	4,169
Issuance of common stock in connection with amendments to Credit Agreement (in shares)		77,922
Issuance of common stock in connection with amendments to Credit Agreement	150	$ 47	103
Share-based compensation (in shares)		166,665
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures	548	$ 100	448
Reverse stock split re-allocation	0	$ (4,880)	4,880
Other adjustments due to reverse stock split (in shares)		486
Retirement of treasury stock (in shares)		(626)			(626)
Retirement of treasury stock	0		(71)		$ 71
Repricing of SWK Warrant 1	264		264
Balance (in shares) at Sep. 30, 2016		10,047,969			0
Balance at Sep. 30, 2016	$ (578)	$ 402	$ 165,988	$ (166,968)	$ 0

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (7,940)	$ (7,588)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,090	1,546
Other debt related costs included in interest expense	1,997	758
Termination fees included in payoff of 2013 Loan and Security Agreement	277	0
Provision for bad debt expense	143	26
Share-based compensation expense	548	360
Issuance of common stock in connection with First Amendment to Credit Agreement	50	0
Write-off of SWK Warrant 2	(887)	0
Change in assets and liabilities:
Accounts receivable	(1,981)	(3,518)
Inventories	(914)	135
Other assets	(132)	(570)
Accounts payable, accrued expenses and other liabilities	(332)	1,955
Net cash used in operating activities	(7,081)	(6,896)
Cash flows from investing activities:
Capital expenditures	(287)	(818)
Acquisition of Accountable Health Solutions	0	(4,000)
Net cash used in investing activities	(287)	(4,818)
Cash flows from financing activities:
Borrowings under credit facility	24,528	8,826
Payments under credit facility	(23,563)	(5,431)
Principal payments on Term Loan	(954)	0
Proceeds from issuance of Term Loan	0	5,000
Issuance of common stock and warrants, net of issuance costs	6,183	0
Proceeds related to the exercise of stock options	0	23
Debt issuance costs	(36)	(377)
Net cash provided by financing activities	6,158	8,041
Net decrease in cash and cash equivalents	(1,210)	(3,673)
Cash and cash equivalents at beginning of period	2,035	5,201
Cash and cash equivalents at end of period	825	1,528
Supplemental disclosure of non-cash investing activities:
Fixed assets vouchered but not paid	94	130
Supplemental disclosure of non-cash financing activities:
Issuance of common stock in connection with the Acquisition	0	3,000
Issuance of common stock in connection with Second Amendment to Credit Agreement	100	0
Debt issuance costs vouchered but not paid	0	500
Payoff of 2013 Loan and Security Agreement by SCM	(2,552)	0
Opening outstanding borrowings under 2016 Credit and Security Agreement	3,028	0
Non-cash debt issuance costs	$ 550	$ 0

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Hooper Holmes, Inc. and its subsidiaries (“Hooper Holmes” or the "Company”) provides on-site screenings and flu shots, laboratory testing, risk assessment, and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers. The acquisition of Accountable Health Services, Inc. ("AHS") ("the Acquisition"), which is discussed further in Note 3 to the condensed consolidated financial statements, allows Hooper Holmes to also deliver telephonic health coaching, a wellness portal, data analytics, and reporting services. Hooper Holmes is engaged by the organizations sponsoring such programs, including health and care management companies, broker and wellness companies, disease management organizations, reward administrators, third party administrators, clinical research organizations, and health plans. Hooper Holmes provides these services through a national network of health professionals. The Company's screening business is subject to some seasonality, with second quarter revenues typically dropping below other quarters. Third and fourth quarter revenues are typically the Company's strongest quarters due to increased demand for screenings from mid-August through November related to annual benefit renewal cycles. The Company's wellness services business is more constant, though there are some variations due to the timing of the health coaching programs, which are billed per participant and typically start soon after the conclusion of onsite screening events. In addition to its screening and health and wellness service operations, the Company generates ancillary revenue through the assembly of medical kits for sale to third parties. The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016. Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented. The results of operations for the three and nine month periods ended September 30, 2016 and 2015 , are not necessarily indicative of the results to be expected for any other interim period or the full year. See “Management's Discussion and Analysis of Financial Condition and Results of Operations” for additional information. Prior to 2015, the Company completed the sale of certain assets comprising its Portamedic, Heritage Labs, and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q. On June 15, 2016, the Company completed a one-for-fifteen reverse stock split, in order to regain compliance with the NYSE MKT's minimum market price requirement. As a result, the share and per share information for all periods presented in these unaudited condensed consolidated financial statements have been adjusted to reflect the impact of the reverse stock split. The reverse stock split did not affect the total number of authorized shares of common stock of 240,000,000 shares or the par value of the Company’s common stock at $0.04 . Accordingly, an adjustment was made between additional paid-in-capital and common stock in the condensed consolidated balance sheet to reflect the new values after the reverse stock split. During the third quarter of 2016, the Company elected to update the presentation of its condensed consolidated balance sheet by adding an other current liabilities category and reclassifying certain liabilities such as escheatment, rent escalation reserve, and legal settlement reserve into this new category in the accompanying condensed consolidated balance sheet. The Company believes this provides a more useful and informative depiction of the Company's current liabilities and liquidity. Prior period comparatives have been reclassified to conform to the revised presentation. New Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures. In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods ending after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a $0.2 million reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15. In July 2015, the FASB issued ASU 2015-11, "Inventory (Topic 330): Simplifying the Measurement of Inventory", which changes the measurement basis for inventory from the lower of cost or market to lower of cost and net realizable value and also eliminates the requirement for companies to consider replacement cost or net realizable value less an approximate normal profit margin when determining the recorded value of inventory. The standard is effective for public companies in fiscal years beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its consolidated financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.

Liquidity

Liquidity	9 Months Ended
	Sep. 30, 2016
Liquidity [Abstract]
Liquidity	Liquidity The Company incurred a loss from continuing operations of $7.6 million during the nine month period ended September 30, 2016 , and the Company’s net cash used in operating activities for the nine month period ended September 30, 2016 , was $7.1 million . The Company has managed its liquidity through availability under a revolving credit facility, raising additional equity, and a series of cost reduction initiatives. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future. The uncertainty regarding the Company's ability to generate sufficient cash flows and liquidity to fund operations raises substantial doubt about its ability to continue as a going concern. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company expects to continue to monitor its liquidity carefully, work to reduce this uncertainty, and address its cash needs through a combination of one or more of the following actions: • On January 25, 2016, the Company received $3.4 million , net of issuance costs, in additional equity by issuing 2,601,789 shares of its common stock, $0.04 par value, through a rights offering to current shareholders which was used to fund working capital; • On March 28, 2016, the Company received $1.2 million , net of issuance costs, in additional equity by issuing 666,667 shares of its common stock, $0.04 par value, to 200 NNH, LLC, which was used to fund working capital; • On April 29, 2016, the Company entered into a new Credit and Security Agreement with SCM Specialty Finance Opportunities Fund, L.P. (as defined below) replacing the 2013 Loan and Security Agreement (as defined below). Refer to Note 9 to the condensed consolidated financial statements for additional discussion. • Beginning on September 15, 2016, the Company received $1.6 million , net of issuance costs, in additional equity by issuing 1,333,333 shares of its common stock, $0.04 par value, and warrants (the "Private Offering Warrants") to purchase up to an additional 1,333,333 shares of its common stock at an exercise price of $2.00 per share to various investors in a private offering (the "Private Offering"). Also, on October 14, 2016, the Company issued an additional 55,556 shares of its common stock, $0.04 par value, and Private Offering Warrants to purchase up to an additional 55,556 shares of its common stock at an exercise price of $2.00 per share with a value of $0.1 million in the Private Offering. The proceeds from the Private Offering were used to fund working capital. The Private Offering Warrants are exercisable, exclusively on a cashless basis, beginning six months after the date of issuance and ending on the fourth anniversary of the date of issuance. The warrants provide that the Company can call the warrants if the closing price of its Common Stock equals or exceeds $3.00 per share for ten consecutive trading days with a minimum trading volume of 100,000 shares per day, subject to certain additional conditions set forth in the warrants. The exercise price of the warrants is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like. The warrants grant the holder certain piggyback registration rights. The warrants were classified as equity, and as such, the Company allocated the proceeds from the stock issuances, net of issuance costs, to the warrants using the relative fair value method. • The Company will continue to aggressively seek new and return business from its existing customers and expand its presence in the health and wellness marketplace; • The Company will continue to analyze and implement further cost reduction initiatives and efficiency improvements (see Note 10 to the condensed consolidated financial statements). The Company's primary sources of liquidity are cash and cash equivalents as well as availability under a Credit and Security Agreement (the "2016 Credit and Security Agreement") with SCM Specialty Finance Opportunities Fund, L.P. ("SCM"). At September 30, 2016 , the Company had $0.8 million in cash and cash equivalents and had $4.8 million of outstanding borrowings under the 2016 Credit and Security Agreement, with unused borrowing capacity of $1.1 million . As of November 10, 2016 , the Company had $5.3 million of outstanding borrowings with unused borrowing capacity of $1.7 million . Any borrowings on the unused borrowing capacity are at the discretion of SCM. As of September 30, 2016 , the Company also owed approximately $4.0 million under an existing term loan (the "Term Loan"), which is governed by the terms of a credit agreement (the "Credit Agreement") with SWK Funding LLC ("SWK") and was used to fund the cash component of the Acquisition. Each of these agreements contain certain financial covenants, including various affirmative and negative covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements, which the Company did not comply with as of September 30, 2016 . Noncompliance with these covenants constitutes an event of default. Accordingly, SCM reserves the right to terminate access to the unused borrowing capacity under the 2016 Credit and Security Agreement, while both lenders reserve the right to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral. The Company and the lenders are discussing the terms of waivers of the covenant violations, but there can be no assurance that the lenders will grant such waivers. If the Company is unable to obtain waivers, the lenders could elect to accelerate the repayment of all amounts outstanding under the 2016 Credit and Security Agreement and the Credit Agreement and they could exercise their remedies with respect to the Company’s collateral, which would have a material adverse impact on the Company’s business operations and financial condition. Similar results could arise if the Company is unable to comply with financial covenants in the future and is unable to modify the covenants, obtain applicable waivers, or find new or additional lenders. For additional information regarding the 2016 Credit and Security Agreement, Credit Agreement, and the related covenants, see Note 9 to the condensed consolidated financial statements. The Company has historically used availability under a revolving credit facility to fund operations. The Company experiences a lag between the payment of certain operating expenses and the subsequent billing and collection of the associated revenue based on health and wellness customer payment terms. To illustrate, in order to conduct successful screenings, the Company must expend cash to deliver the equipment and supplies required for the screenings. The Company must also expend cash to pay the health professionals and site management conducting the screenings. All of these expenditures are incurred in advance of the customer invoicing process and ultimate cash receipts for services performed. Given the seasonal nature of the Company's operations, which are largely dependent on second half volumes, management expects to continue using a revolving credit facility in 2016 and beyond. The Company has contractual obligations related to operating leases and employment contracts which could adversely affect liquidity. The Company is currently in default on three real estate leases for space that the Company no longer needs. Two of the leases were assigned to the Company through the Acquisition, and the third, which is partially subleased, relates to the discontinued Hooper Holmes Services business. The Company is working with the landlords to terminate these leases on mutually acceptable terms. The Company’s ability to satisfy its liquidity needs and meet future covenants is dependent on growing revenues and improving profitability. These profitability improvements primarily include expansion of the Company’s presence in the health and wellness marketplace through new sales to direct customers, retaining existing customers, and capitalizing on the opportunities presented by its channel partners. The Company must increase screening, telephonic health coaching, and wellness portal volumes in order to cover its fixed cost structure and improve gross profits. These improvements may be outside of management’s control. If the Company is unable to increase volumes or control operating costs, liquidity may be adversely affected. There can be no assurance that cash flows from operations, combined with any potential additional borrowings available to the Company, will be obtainable in an amount sufficient to enable the Company to repay its indebtedness, cure matters of default, or to fund other liquidity needs. If the Company continues to be unable to comply with its financial covenants and in the event that the Company were unable to obtain waivers, modify the covenants, or find new or additional lenders, the lenders would then be able to accelerate the repayment of all amounts outstanding and exercise remedies with respect to collateral, and SCM would be able to restrict access to the Company's availability under the 2016 Credit and Security Agreement, which would have a material adverse impact on the Company's business.

Acquisition

Acquisition	9 Months Ended
	Sep. 30, 2016
Business Combinations [Abstract]
Acquisition	Acquisition The Company entered into and consummated the Purchase Agreement on April 17, 2015, among the Company and certain of its subsidiaries, Accountable Health Solutions, Inc. (the "Seller" or "AHS") and Accountable Health, Inc. (the "Shareholder"). Pursuant to the Purchase Agreement, the Company acquired the assets and certain liabilities representing the health and wellness business of the Seller for approximately $7.0 million - $4.0 million in cash and up to 433,333 shares of the Company’s common stock, $0.04 par value, with a value of $3.0 million , which was subject to a working capital adjustment as described in the Purchase Agreement. At the closing of the Purchase Agreement, the Company issued and delivered 371,739 shares of Common Stock to the Shareholder at closing and issued and held back 21,739 shares of Common Stock for the working capital adjustment, which were subsequently released on October 9, 2015, and 39,855 shares of Common Stock for indemnification purposes. No additional shares will be issued under the terms of the Purchase Agreement. The shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, which provides an exemption for private offerings of securities. In order to fund the Acquisition, the Company entered into and consummated the Credit Agreement with SWK on April 17, 2015. Refer to Note 9 of the condensed consolidated financial statements for discussion of the Credit Agreement and related warrants. The Acquisition was treated as a purchase in accordance with Accounting Standards Codification (ASC) 805, Business Combinations , which requires allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed in the transaction. The allocation of purchase price is based on management’s judgment after evaluating several factors, including a valuation assessment. The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows: (in thousands) Accounts receivable, net of allowance of $2 $ 918 Inventory and other current assets 117 Fixed assets 123 Customer portal (existing technologies) 4,151 Customer relationships 2,097 Goodwill 633 Accounts payable and accrued expenses (743 ) Deferred revenue (296 ) Purchase Price $ 7,000 Intangible assets acquired include existing technology in the form of a customer-facing wellness portal and customer relationships. The fair value of the customer relationships acquired was determined using the excess earnings method under the income approach for customer relationships; and the fair value of the wellness portal software was determined using the replacement cost method. The estimated useful life for the wellness portal and customer relationships is 4 years and 8 years , respectively. Amortization is recorded on a straight-line basis over the estimated useful life of the asset. The Company recorded amortization expense as a component of cost of operations of $0.2 million and $0.8 million , respectively, and amortization expense as a component of selling, general, and administrative expenses of $0.1 million and $0.2 million , respectively, during the three and nine month periods ended September 30, 2016 . The Company recorded amortization expense as a component of cost of operations of $0.2 million and $0.5 million , respectively, and amortization expense as a component of selling, general and administrative expenses of $0.1 million and $0.1 million , respectively, during the three and nine month periods ended September 30, 2015 . The goodwill of $0.6 million was recorded in one reporting unit, the health and wellness operations, and is deductible for tax purposes. The consolidated statement of operations for the three and nine month periods ended September 30, 2016 , includes revenue of $3.4 million and $8.6 million , respectively, attributable to AHS. Disclosure of the earnings contribution from the AHS business is not practicable, as the Company has already integrated operations. The following table provides unaudited pro forma results of operations for the three and nine month periods ended September 30, 2015 , as if AHS was part of operations on the first day of the 2014 fiscal year. (in thousands) Three Months Ended Nine Months Ended September 30, September 30, 2015 2015 Pro forma revenues $ 9,272 $ 25,023 Pro forma net loss from continuing operations $ (2,060 ) $ (7,912 ) These pro forma results are based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the Company been a combined company during the periods presented, nor are they indicative of the consolidated results of operations in future periods. The pro forma results for the nine month period ended September 30, 2015 , include pre-tax adjustments for amortization of intangible assets of $0.3 million . Pro forma results for the three and nine month periods ended September 30, 2015 , include pre-tax adjustments for the elimination of acquisition costs of $0.1 million and $0.7 million , respectively.

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Loss Per Share	Loss Per Share Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period. Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. The calculation of loss per common share on a basic and diluted basis was the same for the three and nine month periods ended September 30, 2016 and 2015 , because the inclusion of dilutive common stock equivalents, the SWK Warrant #1 (as defined in Note 9 to the condensed consolidated financial statements) issued in connection with the Acquisition, and the Private Offering Warrants would have been anti-dilutive for all periods presented. The Company has granted options to purchase shares of the Company's common stock through employee stock plans with the weighted average options outstanding as of September 30, 2016 and 2015 , being 356,288 and 277,529 , respectively, SWK Warrant #1 to purchase 543,478 shares issued to SWK, and the Private Offering Warrants to purchase 1,333,333 shares issued in the Private Offering were outstanding as of September 30, 2016 , but are anti-dilutive because the Company is in a net loss position.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	Share-Based Compensation Employee Share-Based Compensation Plans - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. There were no options for the purchase of shares granted under the 2008 Plan during the three month periods ended September 30, 2016 and 2015 . During the nine month periods ended September 30, 2016 and 2015 , the Company granted 153,332 and 40,000 options, respectively, for the purchase of shares under the 2008 Plan. As of September 30, 2016 , 42,124 shares remain available for grant under the 2008 Plan. On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan, as subsequently amended and restated, (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. During the three and nine month periods ended September 30, 2016 , there were no options for the purchase of shares granted under the 2011 Plan. During the three and nine month periods ended September 30, 2015 , there were 16,667 and 46,667 options, respectively, for the purchase of shares granted under the 2011 Plan. There were no stock awards granted under the 2011 Plan during the three month period ended September 30, 2016 . During the nine month period ended September 30, 2016 , the Company granted a total of 166,665 stock awards under the 2011 Plan to non-employee members of the Board of Directors that immediately vested. During the three and nine month periods ended September 30, 2015 , the Company granted 33,333 and 36,111 stock awards, respectively, under the 2011 Plan to non-employee members of the Board of Directors that immediately vested. As of September 30, 2016 , 243,693 shares remain available for grant under the 2011 Plan. There were no options granted during three month period ended September 30, 2016 . The fair value of the stock options granted during the nine month period ended September 30, 2016 , were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: Nine Months Ended September 30, 2016 Expected life (years) 5.1 Expected volatility 81.0% Expected dividend yield —% Risk-free interest rate 1.4% Weighted average fair value of options granted during the period $1.33 The following table summarizes stock option activity for the nine month period ended September 30, 2016 : Number of Options Weighted Average Exercise Price Per Option Weighted Average remaining Contractual Life (years) Aggregate Intrinsic Value (in thousands) Outstanding balance at December 31, 2015 286,568 $ 6.46 Granted 153,332 2.05 Exercised — — Forfeited and Expired (46,690 ) 5.43 Outstanding balance at September 30, 2016 393,210 4.87 8.23 $0 Options exercisable at September 30, 2016 177,807 $ 7.15 7.07 $0 There were no options exercised during the nine month period ended September 30, 2016 . There were 3,333 options with a weighted average exercise price of $6.75 exercised during the nine month period ended September 30, 2015 . Options for the purchase of an aggregate of 66,668 shares of common stock vested during the nine month period ended September 30, 2016 , and the aggregate fair value at grant date of these options was $0.3 million . As of September 30, 2016 , there was approximately $0.2 million of total unrecognized compensation cost related to stock options. The cost is expected to be recognized over a weighted average period of 1.93 years. The Company recorded $0.1 million and $0.5 million , respectively, of share-based compensation expense in selling, general, and administrative expenses for the three and nine month periods ended September 30, 2016 . The Company recorded $0.2 million and $0.4 million , respectively, of share-based compensation expense in selling, general and administrative expenses for the three and nine month periods ended September 30, 2015 .

Inventories

Inventories	9 Months Ended
	Sep. 30, 2016
Inventory Disclosure [Abstract]
Inventories	Inventories Included in inventories at September 30, 2016 , and December 31, 2015 , are $0.9 million and $0.3 million , respectively, of finished goods and $0.6 million and $0.3 million , respectively, of components.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The Company recorded Goodwill of $0.6 million as of September 30, 2016 , and December 31, 2015 . Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below. September 30, 2016 December 31, 2015 (in thousands) Gross Carrying Amount Accumulated Amortization Intangibles Assets, net Gross Carrying Amount Accumulated Amortization Intangibles Assets, net Portal $ 4,151 $ 1,510 $ 2,641 $ 4,151 $ 732 $ 3,419 Customer relationships 2,097 382 1,715 2,097 185 1,912 Total $ 6,248 $ 1,892 $ 4,356 $ 6,248 $ 917 $ 5,331 Amortization expense for the three and nine month periods ended September 30, 2016 , was $0.3 million and $1.0 million , respectively. Amortization expense for the three and nine month periods ended September 30, 2015 , was $0.3 million and $0.6 million , respectively. Based on the Company's recent financial performance and negative equity, management determined a review of impairment of long-lived assets and goodwill was necessary as of September 30, 2016 . The analysis indicated no impairment charges for long-lived assets or goodwill was required at September 30, 2016 .

Restructuring Charges

Restructuring Charges	9 Months Ended
	Sep. 30, 2016
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges At September 30, 2016 , there was a $0.5 million liability related to the Company's obligation under a lease related to the discontinued Hooper Holmes Services operations center, which is recorded in other current and long-term liabilities in the accompanying condensed consolidated balance sheet. Charges recorded during the three and nine month periods ended September 30, 2016 , were recorded as a component of discontinued operations. The following table provides a summary of the activity in the restructure accrual for the nine month period ended September 30, 2016 : (in thousands) December 31, 2015 Adjustments Payments September 30, 2016 Facility closure obligation $ 657 $ 166 $ (351 ) $ 472

Debt

Debt	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Debt	Debt As of September 30, 2016 , the Company maintained the 2016 Credit and Security Agreement and the Term Loan provided by the Credit Agreement. The following table summarizes the Company's outstanding borrowings: (in thousands) September 30, 2016 December 31, 2015 2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015) $ 4,769 $ 3,278 Term Loan 4,046 5,000 Discount on Term Loan (1,500 ) (2,785 ) Unamortized debt issuance costs related to Term Loan (391 ) (163 ) Total debt 6,924 5,330 Short-term portion (6,924 ) (5,330 ) Total long-term debt, net $ — $ — The following table summarizes the components of interest expense for the three and nine month periods ended September 30, 2016 and 2015 : (in thousands) Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Interest expense on Term Loan (interest at LIBOR, plus 14%) $ 171 $ 188 $ 512 $ 342 Interest expense on 2013 Loan and Security Agreement — 20 49 24 Interest expense on 2016 Credit and Security Agreement 72 — 120 — Accretion of termination fees (over term of Term Loan at rate of 8%) 53 21 144 48 Amortization of debt issuance costs 103 48 226 328 Write-off of debt issuance costs related to 2013 Loan and Security Agreement — — 282 — Amortization of debt discount associated with the SWK warrants 479 185 1,286 429 Mark to market of SWK Warrant #2 — (74 ) 59 (74 ) Total $ 878 $ 388 $ 2,678 $ 1,097 2016 Credit and Security Agreement On April 29, 2016, the Company entered into the 2016 Credit and Security Agreement with SCM, as amended on August 15, 2016. The 2016 Credit and Security Agreement provides the Company with a revolving credit facility, the proceeds of which are to be used for general working capital purposes and capital expenditures. The 2016 Credit and Security Agreement replaced the 2013 Loan and Security Agreement, eliminating the requirement of the Company to issue SWK Warrant #2 (as defined below) for the purchase of common stock valued at $1.25 million to SWK, the holder of the Company’s Credit Agreement. An early termination fee of $140,000 , approximately $30,000 of legal fees, and approximately $107,000 of other ordinary course fees were accelerated due to the termination of the 2013 Loan and Security Agreement and were rolled into the opening outstanding borrowings under the 2016 Credit and Security Agreement with SCM. The corresponding expense is reflected in transaction costs in the condensed consolidated statement of operations during the nine month period ended September 30, 2016 . In addition, approximately $0.3 million of unamortized debt issuance costs related to the 2013 Loan and Security Agreement were written off and recorded in interest expense in the condensed consolidated statement of operations during the nine month period ended September 30, 2016 . Under the terms of the 2016 Credit and Security Agreement, SCM makes cash advances to the Company in an aggregate principal at any one time outstanding not to exceed $7 million , subject to certain loan balance limits based on the value of the Company’s eligible collateral (the “Revolving Loan Commitment Amount”). The 2016 Credit and Security Agreement has a term of three years , expiring on April 29, 2019. As of September 30, 2016 , the Company had $4.8 million of outstanding borrowings under the 2016 Credit and Security Agreement with unused borrowing capacity of $1.1 million . As of November 10, 2016 , the Company had $5.3 million of outstanding borrowings, with unused borrowing capacity of $1.7 million . Any borrowings on the unused borrowing capacity are at the discretion of SCM. Borrowings under the 2016 Credit and Security Agreement bear interest at a fluctuating rate that when annualized is equal to the Prime Rate plus 5.5% , subject to increase in the event of a default. The Company paid SCM a $140,000 facility fee, and monthly, SCM will receive an unused line fee equal to one-half of one percent ( 0.5% ) per annum of the difference derived by subtracting (i) the greater of (x) the average daily outstanding balance under the Revolving Facility during the preceding month and (y) the Minimum Balance, from (ii) the Revolving Loan Commitment Amount and also a collateral management fee equal to one-half of one percent ( 0.5% ) per annum of the Revolving Loan Commitment Amount. As of September 30, 2016 , the remaining balance in debt issuance costs recorded in Other Assets on the condensed consolidated balance sheet was $0.3 million . Borrowings under the Agreement are secured by a security interest in all existing and after-acquired property of the Company, including, but not limited to, its receivables (which are subject to a lockbox account arrangement), inventory, and equipment. On August 15, 2016, the Company entered into the First Amendment to Credit and Security Agreement and Limited Waiver and Forbearance (the “First Amendment”), which required certain conditions to be satisfied as of September 30, 2016, for the First Amendment to become permanent. The First Amendment contains customary representations and warranties and various affirmative and negative covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements. Noncompliance with these covenants constitutes an event of default. Minimum aggregate revenue must not be less than $34.0 million for the twelve months ended September 30, 2016, $38.0 million for the twelve months ending December 31, 2016, $41.0 million for the twelve months ending March 31, 2017, and $42.0 million for the twelve months ending each fiscal quarter thereafter. Adjusted EBITDA must not be less than negative $2.0 million for the nine months ended September 30, 2016, negative $0.5 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending each fiscal quarter thereafter. In addition, consolidated unencumbered liquid assets must not be less than $1 on the last day of the fiscal quarter ended September 30, 2016, $0.5 million on the last day of the fiscal quarter ending December 31, 2016, and $0.75 million on the last day of any fiscal quarter thereafter. The Company was not in compliance with the adjusted EBITDA covenant under the First Amendment as of September 30, 2016 . The Company and SCM are discussing the terms of a waiver of the covenant violation, but there can be no assurance that SCM will grant such a waiver. If the Company is unable to obtain a waiver, SCM could elect to accelerate the repayment of all amounts outstanding under the 2016 Credit and Security Agreement and exercise their remedies with respect to the Company’s collateral, which would have a material adverse impact on the Company’s business. Similar results could arise if the Company is unable to comply with financial covenants in the future and is unable to modify the covenants or find new or additional lenders. Credit Agreement In order to fund the Acquisition, the Company entered into the Credit Agreement with SWK on April 17, 2015, as amended on February 25, 2016, March 28, 2016, and August 15, 2016. The Credit Agreement provides the Company with a $5.0 million Term Loan. The proceeds of the Term Loan were used to pay certain fees and expenses related to the negotiation and consummation of the Purchase Agreement and the Acquisition described in Note 3 and general corporate purposes. The Company paid SWK an origination fee of $0.1 million . The Term Loan is due and payable on April 17, 2018. The Company is also required to make quarterly revenue-based payments in an amount equal to eight and one-half percent ( 8.5% ) of yearly aggregate revenue up to and including $20 million , seven percent ( 7% ) of yearly aggregate revenue greater than $20 million up to and including $30 million , and five percent ( 5% ) of yearly aggregate revenue greater than $30 million . The revenue-based payment will be applied to fees and interest, and any excess to the principal of the Term Loan. Revenue-based payments commenced in February 2016, and the maximum principal portion of the aggregate revenue-based payment is capped at $600,000 per quarter. The Third Amendment (defined below) waived the August 2016 payment and revised the November 2016 payment such that the maximum principal portion of the aggregate revenue-based payment is capped at $300,000 . The Company evaluated the application of ASC 470-50 and ASC 470-60 and concluded that the revised terms in the Third Amendment did not constitute a troubled debt restructuring, and the amendment was accounted for as a debt modification rather than a debt extinguishment. During the nine month period ended September 30, 2016 , the Company made principal payments to SWK of $1.0 million , and paid approximately $0.4 million of interest. The outstanding principal balance under the Credit Agreement bears interest at an adjustable rate per annum equal to the LIBOR Rate (subject to a minimum amount of one percent ( 1.0% )) plus fourteen percent ( 14.0% ) and is due and payable quarterly, in arrears, which commenced on August 14, 2015. Upon the earlier of (a) the maturity date on April 17, 2018, or (b) full repayment of the Term Loan, whether by acceleration or otherwise, the Company is required to pay an exit fee equal to eight percent ( 8% ) of the aggregate principal amount of all term loans advanced under the Credit Agreement. The Company is recognizing the exit fee over the term of the Term Loan through an accretion accrual to interest expense using the effective interest method. The Credit Agreement contains a cross-default provision that can be triggered if the Company has more than $0.25 million in debt outstanding under the 2016 Credit and Security Agreement and the Company fails to make payments to SCM when due or if SCM is entitled to accelerate the maturity of debt in response to a default situation under the 2016 Credit and Security Agreement, which may include violation of any financial covenants. As security for payment and other obligations under the 2016 Credit and Security Agreement, SCM holds a security interest in all of the Company's, and its subsidiary guarantors', existing and after-acquired property, including receivables (which are subject to a lockbox account arrangement), inventory and equipment. Additionally, SWK holds a security interest for final and indefeasible payment. The security interest held by SWK is in substantially all of the Company's assets and the Company's subsidiaries. In connection with the execution of the Credit Agreement, the Company issued SWK a warrant (the "SWK Warrant #1") to purchase 543,478 shares of the Company’s common stock. As part of the conditions in the Third Amendment (defined below), the Company modified the exercise price of the SWK Warrant #1 to $1.30 per share as of September 30, 2016, recording the change in fair value of the SWK Warrant #1 of $0.3 million in accumulated paid-in capital in the condensed consolidated balance sheet. The SWK Warrant #1 is exercisable after October 17, 2015, and up to and including April 17, 2022. The SWK Warrant #1 is exercisable on a cashless basis. The exercise price of the warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like. The warrant grants the holder certain piggyback registration rights. The warrant was considered equity classified, and as such, the Company allocated the proceeds from the Term Loan to the warrant using the relative fair value method. Further, pursuant to the Credit Agreement, if the 2013 Loan and Security Agreement was not repaid in full and terminated, and all liens securing the 2013 Loan and Security Agreement were not released, on or prior to April 30, 2016, as amended in the First Amendment to the Credit Agreement dated February 25, 2016, the Company agreed to issue an additional warrant (the “SWK Warrant #2”) to SWK to purchase common stock valued at $1.25 million , with an exercise price of the closing price on April 30, 2016. In accordance with the relevant accounting guidance, the SWK Warrant #2 was determined to be an embedded derivative. The fair value of both of the SWK warrants at the inception of the Credit Agreement of approximately $3.6 million was recorded as a debt discount, and is being amortized through interest expense over the term of the Credit Agreement using the effective interest method. The Company valued both warrants using the Black-Scholes pricing model, which utilizes Level 3 Inputs. For the SWK Warrant #1, the Company utilized volatility of 85.0% , a risk-free rate of 1.4% , dividend rate of zero , and term of 7 years, which is consistent with the exercise period of the Warrant. For the SWK Warrant #2, the Company utilized volatility of 80.0% , a risk-free rate of 2.1% , dividend rate of zero , and term of 7 years, which is consistent with the exercise period of the warrant. The requirement of the Company to issue the SWK Warrant #2 was eliminated when the Company entered into the 2016 Credit and Security Agreement with SCM, which is discussed further above. Accordingly, during the nine month period ended September 30, 2016 , the Company recorded $0.9 million in other income in the condensed consolidated statement of operations related to the write-off of the derivative liability associated with the SWK Warrant #2. On March 28, 2016, the Company entered into the Second Amendment to the Credit Agreement (the "Second Amendment") which required the Company to issue shares of its common stock, $0.04 par value, with a value of $100,000 to SWK, which the Company issued during the first quarter of 2016 and recorded as debt issuance costs as a direct deduction to short-term debt on the condensed consolidated balance sheet as of September 30, 2016 . On August 15, 2016, the Company entered into the Third Amendment to Credit Agreement and Limited Waiver and Forbearance (the “Third Amendment”), which required certain conditions to be satisfied as of September 30, 2016, for the Third Amendment to become permanent. The Third Amendment contains customary representations and warranties and various affirmative and negative covenants including minimum aggregate revenue, adjusted EBITDA, and consolidated unencumbered liquid assets requirements. Noncompliance with these covenants constitutes an event of default. Minimum aggregate revenue must not be less than $34.0 million for the twelve months ended September 30, 2016, $38.0 million for the twelve months ending December 31, 2016, $41.0 million for the twelve months ending March 31, 2017, and $42.0 million for the twelve months ending each fiscal quarter thereafter. Adjusted EBITDA must not be less than negative $2.0 million for the nine months ended September 30, 2016, negative $0.5 million for the twelve months ending December 31, 2016, $0.5 million for the twelve months ending March 31, 2017, $0.9 million for the twelve months ending June 30, 2017, and $2.5 million for the twelve months ending each fiscal quarter thereafter. In addition, consolidated unencumbered liquid assets must not be less than $1 on the last day of the fiscal quarter ended September 30, 2016, $0.5 million on the last day of the fiscal quarter ending December 31, 2016, and $0.75 million on the last day of any fiscal quarter thereafter. The Company was not in compliance with the adjusted EBITDA covenant under the Third Amendment as of September 30, 2016 . The Company and SWK are discussing the terms of a waiver of the covenant violation, but there can be no assurance that SWK will grant such a waiver. If the Company is unable to obtain a waiver, SWK could elect to accelerate the repayment of all amounts outstanding under the Credit Agreement and exercise their remedies with respect to the Company’s collateral, which would have a material adverse impact on the Company’s business. Similar results could arise if the Company is unable to comply with financial covenants in the future and is unable to modify the covenants or find new or additional lenders.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company leases its corporate headquarters in Olathe, Kansas, which includes the health and wellness operations center, under an operating lease which expires in 2018. The Company leases its AHS operations centers in Des Moines, Iowa and Indianapolis, IN, under operating leases which expire in 2018. The Company also leases copiers and other miscellaneous equipment. These leases expire at various times through 2017. The Company is obligated under a lease related to the discontinued Hooper Holmes Services operations center through 2018 and has ceased use of this facility. The Company has recorded a facility closure obligation of $0.5 million as of September 30, 2016 , related to this lease, which is recorded in other current and long-term liabilities in the accompanying condensed consolidated balance sheet. The Company has employment agreements with certain employees that provide for payment of base salary for up to a one year period in the event their employment with the Company is terminated in certain circumstances, including following a change in control, as further defined in the agreements. The Company incurred certain severance and other costs related to its ongoing initiatives to increase the flexibility of its cost structure that were recorded in selling, general, and administrative expenses, and at September 30, 2016 , the Company recorded a $0.2 million liability related to these initiatives in other current liabilities in the accompanying condensed consolidated balance sheet. From time to time, the Company is subject to federal and state tax audits and related governmental inquiries into matters such as income tax returns, sales and use tax returns, employment classification of its workers, and wage and hour law compliance. The Company is currently under examination by the Internal Revenue Service (the “IRS”) for the calendar years 2013, 2014, and 2015 with respect to its classification of certain of its health professionals as independent contractors rather than employees. This examination could lead to proposed adjustments to its federal employment taxes for the periods in question, but the IRS has not yet issued an assessment. The Company believes that it has properly classified these workers as independent contractors, but there can be no assurances of a favorable outcome for the Company and given the ongoing status of the examination, we are unable at this time to provide an estimate of the range of loss, if any.

Litigation

Litigation	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Litigation	Litigation The Company, in the normal course of business, is a party to various claims and other legal proceedings. In the opinion of management, the Company has legal defenses and/or insurance coverage (subject to deductibles) with respect to all of its pending legal actions. If management believes that a material loss not covered by insurance arising from these actions is probable and can reasonably be estimated, the Company may record the amount of the estimated loss or, if a loss cannot be estimated but the minimum liability may be estimated using a range and no point is more probable than another, the Company may record the minimum estimated liability. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of all pending legal actions, individually and in the aggregate, will not have a material adverse effect on the Company's financial position that is inconsistent with its loss reserves or on its overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur that exceed any amounts reserved for such losses. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods. On May 24, 2012, a complaint was filed against the Company in the United States District Court for the District of New Jersey alleging, among other things, that the Company failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleged, should be treated as employees for purposes of federal law. The complaint sought an award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company filed an answer denying the substantive allegations therein. On August 1, 2014, the Magistrate Judge issued a Report and Recommendation to conditionally certify the class of all contract examiners from August 16, 2010, to the present. On August 29, 2014, the Company submitted its objections to the Report and Recommendation of the Magistrate Judge. The Magistrate suspended ruling concerning those objections while the parties pursued the possibility of a settlement. On April 29, 2016, the Company reached a preliminary understanding with the plaintiffs with respect to a settlement of the lawsuit involving a release of all claims by the plaintiffs and the Company's establishment of a settlement fund of $0.45 million . Accordingly, as of September 30, 2016 , the Company had accrued $ 0.45 million related to this matter versus $0.3 million as of December 31, 2015. The litigation accrual for all periods was included in the other current liabilities line item on the condensed consolidated balance sheet. The additional expense of $0.15 million recorded during the nine month period ended September 30, 2016 , is included in the discontinued operations line item on the condensed consolidated statements of operations. On August 5, 2016, the Magistrate approved the parties’ definitive settlement agreement. The claim is not covered by insurance, and the Company incurred legal costs to defend the litigation which are recorded in discontinued operations. This matter relates to the former Portamedic service line for which the Company retained liability.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company's income tax expense was not material for any period presented in the condensed consolidated statement of operations. No amounts were recorded for unrecognized tax benefits or for the payment of interest and penalties during the three and nine month periods ended September 30, 2016 and 2015 . No federal or state tax benefits were recorded relating to the current year loss. The Company continues to believe that a full valuation allowance is required on its net deferred tax assets, with the exception of deferred income tax on the liabilities of certain indefinite-lived intangibles. The tax years 2012 through 2015 may be subject to federal examination and assessment. Tax years from 2007 through 2011 remain open solely for purposes of federal and certain state examination of net operating loss and credit carryforwards. State income tax returns may be subject to examination for tax years 2011 through 2015, depending on state tax statute of limitations. As of December 31, 2015 , the Company had U.S. federal and state net operating loss carryforwards of $167.2 million and $149.8 million , respectively. There has been no significant change in these balances as of September 30, 2016 . The net operating loss carryforwards, if not utilized, will expire in the years 2016 through 2035 . Since the Company had changes in ownership during 2015 and continuing into 2016, additional limitations under IRC Section 382 of the Internal Revenue Code of 1986 may apply to the future utilization of certain tax attributes including net operating loss (“NOL”) carryforwards, other tax carryforwards, and certain built-in losses. The Company has not yet completed its analysis of any impact of these ownership changes. No tax benefit has been reported since a full valuation allowance offsets these tax attributes. However, limitations could apply even if the valuation allowance was released.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: • Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. • Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. • Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company estimated the fair value of the Term Loan and the derivative liability using Level 3 valuation techniques. The estimated fair value of the Term Loan was determined by discounting future projected cash flows using a discount rate commensurate with the risks involved and by using the Black-Scholes valuation model, while the estimated fair value of the derivative liability was determined using the Black-Scholes valuation model. September 30, 2016 December 31, 2015 (in thousands) Face Value Fair Value Carrying Amount Face Value Fair Value Carrying Amount Term Loan $ 5,000 $ 3,865 $ 2,155 $ 5,000 $ 3,837 $ 2,052 Derivative liability $ — $ — $ — $ 1,250 $ 828 $ 828

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's 2015 Annual Report on Form 10-K, filed with the SEC on March 30, 2016. Financial statements prepared in accordance with U.S. GAAP require management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and other disclosures. The financial information included herein is unaudited; however, such information reflects all adjustments that are, in the opinion of the Company's management, necessary for a fair statement of results for the interim periods presented. The results of operations for the three and nine month periods ended September 30, 2016 and 2015 , are not necessarily indicative of the results to be expected for any other interim period or the full year. See “Management's Discussion and Analysis of Financial Condition and Results of Operations” for additional information.
Discontinued Operations	Prior to 2015, the Company completed the sale of certain assets comprising its Portamedic, Heritage Labs, and Hooper Holmes Services businesses. The operating results of these businesses have been segregated and reported as discontinued operations for all periods presented in this Quarterly Report on Form 10-Q.
New Accounting Pronouncements	New Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. This new guidance is effective for the Company in the first quarter of 2018, with early adoption permitted as of the original effective date or first quarter of 2017. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on the consolidated financial statements and related disclosures. In August 2014, the FASB issued ASU No. 2014-15, "Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". This ASU requires management to assess and evaluate whether conditions or events exist, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the financial statements issue date. This standard will be effective for annual periods ending after December 15, 2016, and for annual and interim periods thereafter; early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 will have on the disclosures in Note 2 of the condensed consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, "Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs", which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying value of the debt liability. The Company adopted the provisions of ASU 2015-03 in the first quarter of 2016. The retrospective application of the new standard resulted in a $0.2 million reduction to both noncurrent assets and current liabilities as of December 31, 2015. The debt issuance costs associated with the revolving credit facilities remain classified in noncurrent assets in accordance with ASU 2015-15. In July 2015, the FASB issued ASU 2015-11, "Inventory (Topic 330): Simplifying the Measurement of Inventory", which changes the measurement basis for inventory from the lower of cost or market to lower of cost and net realizable value and also eliminates the requirement for companies to consider replacement cost or net realizable value less an approximate normal profit margin when determining the recorded value of inventory. The standard is effective for public companies in fiscal years beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its consolidated financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)", which is intended to improve financial reporting about leasing transactions. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting (Topic 718)", which is intended to simplify the accounting for share-based compensation. This standard simplifies the accounting for income taxes in relation to share-based compensation, modifies the accounting for forfeitures, and modifies the statutory tax withholding requirements. This standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating the impact the adoption of ASU 2016-09 will have on its consolidated financial position, results of operations or cash flows.
Loss Per Share	Loss Per Share Basic loss per share equals net loss divided by the weighted average common shares outstanding during the period. Diluted loss per share equals net loss divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents.
Fair Value Measurements	Fair Value Measurements The Company determines the fair value measurements used in our consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: • Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. • Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. • Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Acquisition (Tables)

Acquisition (Tables)	9 Months Ended
	Sep. 30, 2016
Business Combinations [Abstract]
Allocation of Purchase Price	The allocation of the purchase price was finalized in the first quarter of 2016 and is as follows: (in thousands) Accounts receivable, net of allowance of $2 $ 918 Inventory and other current assets 117 Fixed assets 123 Customer portal (existing technologies) 4,151 Customer relationships 2,097 Goodwill 633 Accounts payable and accrued expenses (743 ) Deferred revenue (296 ) Purchase Price $ 7,000
Business Acquisition, Pro Forma Information	The following table provides unaudited pro forma results of operations for the three and nine month periods ended September 30, 2015 , as if AHS was part of operations on the first day of the 2014 fiscal year. (in thousands) Three Months Ended Nine Months Ended September 30, September 30, 2015 2015 Pro forma revenues $ 9,272 $ 25,023 Pro forma net loss from continuing operations $ (2,060 ) $ (7,912 )

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Valuation Assumptions	The fair value of the stock options granted during the nine month period ended September 30, 2016 , were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: Nine Months Ended September 30, 2016 Expected life (years) 5.1 Expected volatility 81.0% Expected dividend yield —% Risk-free interest rate 1.4% Weighted average fair value of options granted during the period $1.33
Schedule of Stock Option Activity	The following table summarizes stock option activity for the nine month period ended September 30, 2016 : Number of Options Weighted Average Exercise Price Per Option Weighted Average remaining Contractual Life (years) Aggregate Intrinsic Value (in thousands) Outstanding balance at December 31, 2015 286,568 $ 6.46 Granted 153,332 2.05 Exercised — — Forfeited and Expired (46,690 ) 5.43 Outstanding balance at September 30, 2016 393,210 4.87 8.23 $0 Options exercisable at September 30, 2016 177,807 $ 7.15 7.07 $0

Goodwill and Other Intangible23

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets Subject to Amortization	Intangible assets subject to amortization are amortized on a straight-line basis and are summarized in the table below. September 30, 2016 December 31, 2015 (in thousands) Gross Carrying Amount Accumulated Amortization Intangibles Assets, net Gross Carrying Amount Accumulated Amortization Intangibles Assets, net Portal $ 4,151 $ 1,510 $ 2,641 $ 4,151 $ 732 $ 3,419 Customer relationships 2,097 382 1,715 2,097 185 1,912 Total $ 6,248 $ 1,892 $ 4,356 $ 6,248 $ 917 $ 5,331

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Sep. 30, 2016
Restructuring Charges [Abstract]
Activity in the Restructure Accrual	The following table provides a summary of the activity in the restructure accrual for the nine month period ended September 30, 2016 : (in thousands) December 31, 2015 Adjustments Payments September 30, 2016 Facility closure obligation $ 657 $ 166 $ (351 ) $ 472

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the Company's outstanding borrowings: (in thousands) September 30, 2016 December 31, 2015 2016 Credit and Security Agreement (2013 Loan and Security Agreement as of December 31, 2015) $ 4,769 $ 3,278 Term Loan 4,046 5,000 Discount on Term Loan (1,500 ) (2,785 ) Unamortized debt issuance costs related to Term Loan (391 ) (163 ) Total debt 6,924 5,330 Short-term portion (6,924 ) (5,330 ) Total long-term debt, net $ — $ —
Summary of Components of Interest Expense	The following table summarizes the components of interest expense for the three and nine month periods ended September 30, 2016 and 2015 : (in thousands) Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Interest expense on Term Loan (interest at LIBOR, plus 14%) $ 171 $ 188 $ 512 $ 342 Interest expense on 2013 Loan and Security Agreement — 20 49 24 Interest expense on 2016 Credit and Security Agreement 72 — 120 — Accretion of termination fees (over term of Term Loan at rate of 8%) 53 21 144 48 Amortization of debt issuance costs 103 48 226 328 Write-off of debt issuance costs related to 2013 Loan and Security Agreement — — 282 — Amortization of debt discount associated with the SWK warrants 479 185 1,286 429 Mark to market of SWK Warrant #2 — (74 ) 59 (74 ) Total $ 878 $ 388 $ 2,678 $ 1,097

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value of Term Loan and Derivative Liability	September 30, 2016 December 31, 2015 (in thousands) Face Value Fair Value Carrying Amount Face Value Fair Value Carrying Amount Term Loan $ 5,000 $ 3,865 $ 2,155 $ 5,000 $ 3,837 $ 2,052 Derivative liability $ — $ — $ — $ 1,250 $ 828 $ 828

Basis of Presentation (Details)

Basis of Presentation (Details) $ / shares in Units, $ in Millions	Jun. 15, 2016$ / sharesshares	Sep. 30, 2016$ / sharesshares	Mar. 28, 2016$ / shares	Jan. 25, 2016$ / shares	Dec. 31, 2015USD ($)$ / sharesshares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stock split conversion ratio	0.0667
Common stock, shares authorized (in shares) | shares	240,000,000	240,000,000			240,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.04	$ 0.04	$ 0.04	$ 0.04	$ 0.04
Adjustments for new accounting pronouncement | Noncurrent assets
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred issuance costs, net					$ 0.2
Adjustments for new accounting pronouncement | Current liabilities
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred issuance costs, net					$ 0.2

Liquidity (Details)

Liquidity (Details)	Oct. 14, 2016USD ($)$ / sharesshares	Sep. 15, 2016USD ($)$ / sharesshares	Mar. 28, 2016USD ($)$ / sharesshares	Jan. 25, 2016USD ($)$ / sharesshares	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)operating_lease$ / shares	Sep. 30, 2015USD ($)	Nov. 10, 2016USD ($)	Jun. 15, 2016$ / shares	Dec. 31, 2015USD ($)$ / shares	Apr. 17, 2015shares	Dec. 31, 2014USD ($)
Debt Instrument [Line Items]
Loss from continuing operations					$ (2,051,000)	$ (2,061,000)	$ (7,630,000)	$ (7,506,000)
Net cash used in operating activities of continuing operations							$ 7,081,000	6,896,000
Issuance of common stock and warrants, net of issuance costs			$ 1,200,000	$ 3,400,000
Stock issued (in shares) | shares			666,667	2,601,789
Common stock, par value (in dollars per share) | $ / shares			$ 0.04	$ 0.04	$ 0.04		$ 0.04			$ 0.04	$ 0.04
Cash and cash equivalents					$ 825,000	$ 1,528,000	$ 825,000	$ 1,528,000			$ 2,035,000		$ 5,201,000
Number of operating lease contracts in default | operating_lease							3
Line of credit | 2016 Credit and Security Agreement
Debt Instrument [Line Items]
Borrowings outstanding					4,800,000		$ 4,800,000
Available borrowing availability					$ 1,100,000		$ 1,100,000
Loans payable | Credit agreement
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares			$ 0.04
Number of shares to be purchased under warrant (in shares) | shares												543,478
Exercise price of warrant (in dollars per share) | $ / shares					$ 1.30		$ 1.30
Value of stock issued			$ 100,000
Outstanding borrowings under term loan					$ 4,000,000		$ 4,000,000
Subsequent event
Debt Instrument [Line Items]
Number of shares to be purchased under warrant (in shares) | shares	55,556
Subsequent event | Line of credit | 2016 Credit and Security Agreement
Debt Instrument [Line Items]
Borrowings outstanding									$ 5,300,000
Available borrowing availability									$ 1,700,000
Private Offering Warrants
Debt Instrument [Line Items]
Issuance of common stock and warrants, net of issuance costs		$ 1,600,000
Stock issued (in shares) | shares		1,333,333
Common stock, par value (in dollars per share) | $ / shares		$ 0.04
Private Offering Warrants | Subsequent event
Debt Instrument [Line Items]
Stock issued (in shares) | shares	55,556
Common stock, par value (in dollars per share) | $ / shares	$ 0.04
Share price, minimum (in dollars per share) | $ / shares	$ 3
Consecutive trading days of stocks	10 days
Minimum trading volume (in shares) | $ / shares	$ 100,000
Private Offering
Debt Instrument [Line Items]
Number of shares to be purchased under warrant (in shares) | shares		1,333,333
Exercise price of warrant (in dollars per share) | $ / shares		$ 2
Private Offering | Subsequent event
Debt Instrument [Line Items]
Exercise price of warrant (in dollars per share) | $ / shares	$ 2
Value of stock issued	$ 100,000

Acquisition - Additional Inform

Acquisition - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Apr. 17, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Jun. 15, 2016	Mar. 31, 2016	Mar. 28, 2016	Jan. 25, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Acquisition, cash paid				$ 0	$ 4,000
Common stock, par value (in dollars per share)		$ 0.04		$ 0.04		$ 0.04		$ 0.04	$ 0.04	$ 0.04
Amortization of intangible assets		$ 300	$ 300	$ 1,000	600
Goodwill		633		$ 633						$ 633
AHS acquisition
Business Acquisition [Line Items]
Acquisition, purchase price	$ 7,000
Acquisition, cash paid	$ 4,000
Shared to be issued in acquisition (up to amount) (in shares)	433,333
Common stock, par value (in dollars per share)	$ 0.04
Value of common stock issued in acquisition	$ 3,000
Acquisition, shares delivered at closing (in shares)	371,739
Acquisition, shares held back for working capital adjustment (in shares)	21,739
Acquisition, shares held back for indemnification (in shares)	39,855
Number of additional shares to be issued (in shares)				0
Goodwill							$ 633
Revenues attributable to AHS since the acquisition		3,400		$ 8,600
AHS acquisition | Amortization of Intangible Assets
Business Acquisition [Line Items]
Pro forma amortization of intangible assets					(300)
AHS acquisition | Acquisition-related costs
Business Acquisition [Line Items]
Pro forma amortization of intangible assets			100		700
AHS acquisition | Cost of operations
Business Acquisition [Line Items]
Amortization of intangible assets		200	200	800	500
AHS acquisition | Selling, general and administrative expenses
Business Acquisition [Line Items]
Amortization of intangible assets		$ 100	$ 100	$ 200	$ 100
AHS acquisition | Customer portal (existing technologies)
Business Acquisition [Line Items]
Estimated useful life				4 years
AHS acquisition | Customer relationships
Business Acquisition [Line Items]
Estimated useful life				8 years

Acquisition - Purchase Price Al

Acquisition - Purchase Price Allocation (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Intangible assets	$ 6,248		$ 6,248
Goodwill	633		633
Customer portal (existing technologies)
Business Acquisition [Line Items]
Intangible assets	4,151		4,151
Customer relationships
Business Acquisition [Line Items]
Intangible assets	$ 2,097		$ 2,097
AHS acquisition
Business Acquisition [Line Items]
Accounts receivable, net of allowance of $2		$ 918
Inventory and other current assets		117
Fixed assets		123
Goodwill		633
Accounts payable and accrued expenses		(743)
Deferred revenue		(296)
Purchase Price		7,000
Accounts receivable, allowance		2
AHS acquisition | Customer portal (existing technologies)
Business Acquisition [Line Items]
Intangible assets		4,151
AHS acquisition | Customer relationships
Business Acquisition [Line Items]
Intangible assets		$ 2,097

Acquisition - Pro Forma Results

Acquisition - Pro Forma Results of Operations (Details) - AHS acquisition - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2015
Business Acquisition [Line Items]
Pro forma revenues	$ 9,272	$ 25,023
Pro forma net loss from continuing operations	$ (2,060)	$ (7,912)

Loss Per Share (Details)

Loss Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average options outstanding (in shares)	356,288	277,529
Number of warrants to purchase shares issued (in shares)	543,478
IPO
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of warrants to purchase shares issued (in shares)	1,333,333

Share-Based Compensation - Empl

Share-Based Compensation - Employee Share-Based Compensation Plans (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)			153,332
2008 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)			153,332	40,000
Remaining shares available for grant under the plan (in shares)	42,124		42,124
2011 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)	0	16,667	166,665	46,667
Remaining shares available for grant under the plan (in shares)	243,693		243,693
2011 Plan | Non-employee Members Board of Directors
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)		33,333		36,111

Share-Based Compensation - Stoc

Share-Based Compensation - Stock Option Valuation Assumptions (Details)	9 Months Ended
	Sep. 30, 2016$ / shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected life (years)	5 years 1 month 6 days
Expected volatility (as percent)	81.00%
Expected dividend yield (as percent)	0.00%
Risk-free interest rate (as percent)	1.40%
Weighted average fair value of options granted during the period	$ 1.33

Share-Based Compensation - Opti

Share-Based Compensation - Option Roll-Forward (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015$ / sharesshares
Stock Option Activity [Roll Forward]
Outstanding balance at December 31, 2015 (in shares) | shares	286,568
Options granted (in shares) | shares	153,332
Options exercised (in shares) | shares	0	(3,333)
Options forfeited and expired (in shares) | shares	(46,690)
Outstanding balance at September 30, 2016 (in shares) | shares	393,210
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding balance (weighted average exercise price) at December 31, 2015 (in dollars per share) | $ / shares	$ 6.46
Granted (weighted average exercise price) (in dollars per share) | $ / shares	2.05
Exercised (weighted averaged exercise price) (in dollars per share) | $ / shares	0	$ 6.75
Forfeited and Expired (weighted average exercise price) (in dollars per share) | $ / shares	5.43
Outstanding balance (weighted average exercise price) at September 30, 2016 (in dollars per share) | $ / shares	$ 4.87
Weighted Average Remaining Contractual Life, options outstanding	8 years 2 months 22 days
Aggregate Intrinsic Value of options | $	$ 0
Number of options exercisable at September 30, 2016 (in shares) | shares	177,807
Weighted average exercise price of options exercisable at September 30, 2016 (in dollars per share) | $ / shares	$ 7.15
Weighted Average Remaining Contractual Life, options exercisable	7 years 25 days
Aggregate Intrinsic Value of options | $	$ 0

Share-Based Compensation - Op36

Share-Based Compensation - Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options exercised (in shares)			0	3,333
Exercised (weighted averaged exercise price) (in dollars per share)			$ 0	$ 6.75
Options vested in period (in shares)			66,668
Aggregate fair value of options vested in period			$ 0.3
Unrecognized compensation cost related to stock options	$ 0.2		$ 0.2
Weighted average period for recognition of compensation cost			1 year 11 months 4 days
Share-based compensation expense	$ 0.1	$ 0.2	$ 0.5	$ 0.4

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Inventory Disclosure [Abstract]
Finished goods	$ 0.9	$ 0.3
Components	$ 0.6	$ 0.3

Goodwill and Other Intangible38

Goodwill and Other Intangible Assets (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 633,000		$ 633,000		$ 633,000
Amortization expense	300,000	$ 300,000	1,000,000	$ 600,000
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	6,248,000		6,248,000		6,248,000
Accumulated Amortization	1,892,000		1,892,000		917,000
Intangibles Assets, net	4,356,000		4,356,000		5,331,000
Long-lived assets and goodwill impairment charges			0
Portal
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,151,000		4,151,000		4,151,000
Accumulated Amortization	1,510,000		1,510,000		732,000
Intangibles Assets, net	2,641,000		2,641,000		3,419,000
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,097,000		2,097,000		2,097,000
Accumulated Amortization	382,000		382,000		185,000
Intangibles Assets, net	$ 1,715,000		$ 1,715,000		$ 1,912,000

Restructuring Charges (Details)

Restructuring Charges (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2016USD ($)
Restructuring Charges [Abstract]
Branch closure obligation	$ 500
Facility closure obligation
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	657
Adjustments	166
Payments	(351)
Restructuring reserve, ending balance	$ 472

Debt - Summary of Outstanding B

Debt - Summary of Outstanding Borrowings (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Total debt	$ 6,924	$ 5,330
Short-term portion	(6,924)	(5,330)
Total long-term debt, net	0	0
Line of credit | 2016 Credit and Security Agreement
Debt Instrument [Line Items]
Total debt	4,769
Line of credit | 2013 Loan and Security Agreement
Debt Instrument [Line Items]
Total debt		3,278
Loans payable | Credit agreement
Debt Instrument [Line Items]
Total debt	4,046	5,000
Discount on Term Loan	(1,500)	(2,785)
Unamortized debt issuance costs related to Term Loan	$ (391)	$ (163)

Debt - Summary of Interest Expe

Debt - Summary of Interest Expense Components (Details) - USD ($) $ in Thousands	Apr. 17, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Debt Instrument [Line Items]
Amortization of deferred financing costs		$ 103	$ 48	$ 226	$ 328
Amortization of debt discount associated with the SWK warrants		479	185	1,286	429
Mark to market of SWK Warrant 2		0	(74)	59	(74)
Total		878	388	2,678	1,097
2013 Loan and Security Agreement
Debt Instrument [Line Items]
Write-off of debt issuance costs		0	0	282	0
Loans payable | Credit agreement
Debt Instrument [Line Items]
Interest expense		171	188	512	342
Accretion of termination fees (over term of Term Loan at rate of 8%)		$ 53	21	$ 144	48
Exit fee as a percent of aggregate principal	8.00%	8.00%		8.00%
Line of credit | 2013 Loan and Security Agreement
Debt Instrument [Line Items]
Interest expense		$ 0	20	$ 49	24
Line of credit | 2016 Credit and Security Agreement
Debt Instrument [Line Items]
Interest expense		$ 72	$ 0	$ 120	$ 0
LIBOR | Loans payable | Credit agreement
Debt Instrument [Line Items]
Spread on variable rate (as percent)	14.00%			14.00%

Debt (Details)

Debt (Details) - USD ($)	Aug. 15, 2016	Apr. 29, 2016	Mar. 28, 2016	Apr. 17, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Jun. 15, 2016	Jan. 25, 2016	Dec. 31, 2015
Debt [Line Items]
Mark to market of SWK Warrant 2					$ 0	$ (74,000)	$ 59,000	$ (74,000)
Other income					$ 0	0	$ 887,000	0
Common stock, par value (in dollars per share)			$ 0.04		$ 0.04		$ 0.04		$ 0.04	$ 0.04	$ 0.04
2013 Loan and Security Agreement
Debt [Line Items]
Write-off of debt issuance costs					$ 0	$ 0	$ 282,000	$ 0
2013 Loan and Security Agreement | Interest Expense
Debt [Line Items]
Write-off of debt issuance costs					300,000
Loans payable
Debt [Line Items]
Amount of term loan					5,000,000		5,000,000				$ 5,000,000
Loans payable | 2013 Loan and Security Agreement | Contingently Issuable Warrant
Debt [Line Items]
Value of warrant to be issued is debt instrument is not paid		$ 1,250,000
Loans payable | 2013 Loan and Security Agreement | Loans payable | Transaction Cost
Debt [Line Items]
Debt extinguishment costs, early termination fees		140,000
Debt extinguishment cost, legal fees		30,000
Facility fee amount		107,000
Loans payable | Credit agreement
Debt [Line Items]
Facility fee amount				$ 100,000
Expected term				7 years
Deferred issuance costs, net					$ 391,000		391,000				163,000
Debt covenant, minimum aggregate revenue for twelve month period ending September 30, 2016	$ 34,000,000
Debt covenant, minimum aggregate revenue for twelve month period ending December 31, 2016	38,000,000
Debt covenant, minimum aggregate revenue for twelve month period ending each fiscal quarter thereafter	42,000,000
Debt covenant, minimum EBITDA amount for the nine month period ending September 30, 2016	2,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2016	500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2017	500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2017	900,000
Debt covenant, minimum EBITDA amount for the twelve months ending each fiscal quarter thereafter	2,500,000
Amount of term loan				$ 5,000,000
Maximum aggregate revenue-based payment	300,000			$ 600,000
First principal payment							1,000,000
Interest paid							$ 400,000
Variable rate floor, percent				1.00%
Exit fee as a percent of aggregate principal				8.00%	8.00%		8.00%
Debt covenant, maximum debt outstanding				$ 250,000
Number of shares to be purchased under warrant (in shares)				543,478
Exercise price of warrant (in dollars per share)					$ 1.30		$ 1.30
Term loan, fair value					$ 1,500,000		$ 1,500,000				$ 2,785,000
Expected volatility rate (as percent)				85.00%
Risk free interest rate (as percent)				1.40%
Dividend rate (as percent)				0.00%
Common stock, par value (in dollars per share)			$ 0.04
Value of stock issued			$ 100,000
Loans payable | Credit agreement | Annual Aggregate Revenue Up To And Including $20 million
Debt [Line Items]
Percent of aggregate revenue for quarterly payments				8.50%
Annual aggregate revenue limit				$ 20,000,000
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million
Debt [Line Items]
Percent of aggregate revenue for quarterly payments				7.00%
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million | Minimum
Debt [Line Items]
Annual aggregate revenue limit				$ 20,000,000
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $20 Million Up To And Including $30 Million | Maximum
Debt [Line Items]
Annual aggregate revenue limit				$ 30,000,000
Loans payable | Credit agreement | Annual Aggregate Revenue Greater Than $30 million
Debt [Line Items]
Percent of aggregate revenue for quarterly payments				5.00%
Annual aggregate revenue limit				$ 30,000,000
Loans payable | Credit agreement | Additional Paid-in Capital
Debt [Line Items]
Mark to market of SWK Warrant 2							$ 300,000
Loans payable | Credit agreement | LIBOR
Debt [Line Items]
Spread on variable rate (as percent)				14.00%			14.00%
Loans payable | Credit agreement | Contingently Issuable Warrant
Debt [Line Items]
Value of warrant to be issued is debt instrument is not paid				$ 1,250,000
Expected term				7 years
Term loan, fair value				$ 3,600,000
Expected volatility rate (as percent)				80.00%
Risk free interest rate (as percent)				2.10%
Dividend rate (as percent)				0.00%
Line of credit | 2016 Credit and Security Agreement
Debt [Line Items]
Facility fee amount		140,000
Maximum borrowing capacity		$ 7,000,000
Expected term		3 years
Borrowings outstanding					4,800,000		$ 4,800,000
Available borrowing availability					1,100,000		1,100,000
Commitment fee, percentage (as percent)		0.50%
Collateral fee (as percent)		0.50%
Debt covenant, minimum aggregate revenue for twelve month period ending September 30, 2016	34,000,000
Debt covenant, minimum aggregate revenue for twelve month period ending December 31, 2016	38,000,000
Debt covenant, minimum aggregate revenue for twelve month period ending March 31, 2017	41,000,000
Debt covenant, minimum aggregate revenue for twelve month period ending each fiscal quarter thereafter	42,000,000
Debt covenant, minimum EBITDA amount for the nine month period ending September 30, 2016	2,000,000
Debt covenant, minimum EBITDA amount for the twelve month period ending December 31, 2016	500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending March 31, 2017	500,000
Debt covenant, minimum EBITDA amount for the twelve month period ending June 30, 2017	900,000
Debt covenant, minimum EBITDA amount for the twelve months ending each fiscal quarter thereafter	2,500,000
Line of credit | 2016 Credit and Security Agreement | Last day of fiscal quarter ended September 30, 2016
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	1
Line of credit | 2016 Credit and Security Agreement | Last day of fiscal quarter ended December 31, 2016
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	500,000
Line of credit | 2016 Credit and Security Agreement | Last day of any fiscal quarter thereafter
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	750,000
Line of credit | 2016 Credit and Security Agreement | Other Assets
Debt [Line Items]
Deferred issuance costs, net					300,000		$ 300,000
Line of credit | 2016 Credit and Security Agreement | Prime rate
Debt [Line Items]
Spread on variable rate (as percent)		5.50%
Line of credit | Credit agreement
Debt [Line Items]
Debt covenant, minimum aggregate revenue for twelve month period ending March 31, 2017	41,000,000
Other income					$ 900,000
Line of credit | Credit agreement | Last day of fiscal quarter ended September 30, 2016
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	1
Line of credit | Credit agreement | Last day of fiscal quarter ended December 31, 2016
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	500,000
Line of credit | Credit agreement | Last day of any fiscal quarter thereafter
Debt [Line Items]
Minimum consolidated unencumbered liquid assets required	$ 750,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2016USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Branch closure obligation	$ 0.5
Employment agreements, contract term	1 year
Other Current Liabilities | Employee Severance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Restructuring Reserve	$ 0.2

Litigation (Details)

Litigation (Details) - USD ($) $ in Thousands	Apr. 29, 2016	Sep. 30, 2016	Dec. 31, 2015
Loss Contingencies [Line Items]
Settlement fund amount	$ 450
Loss from operations | Discontinued operations
Loss Contingencies [Line Items]
Loss recognized in period		$ 150
Accrued expenses
Loss Contingencies [Line Items]
Accrual of loss		$ 450	$ 300

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 0	$ 0	$ 0	$ 0
Interest and penalty payments	$ 0	$ 0	0	0
Current federal tax benefit			0	0
Current state tax benefit			$ 0	$ 0
U.S. Federal
Operating loss carryforwards, subject to expiration					$ 167,200,000
State
Operating loss carryforwards, subject to expiration					$ 149,800,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability - Face Value	$ 0	$ 1,250
Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Term Loan - Face Value	5,000	5,000
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	828
Carrying Amount | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Term Loan, Carrying Amount	2,155	2,052
Level 3 | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	828
Level 3 | Fair Value | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Term Loan, Fair Value	$ 3,865	$ 3,837